{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:10:12Z","timestamp":1790885412341,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Development Plan Project of JiLin Provincial Science and Technology","award":["YDZJ202401259ZYTS"],"award-info":[{"award-number":["YDZJ202401259ZYTS"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10495-026-02349-4","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:36:58Z","timestamp":1779086218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ZDHHC14-driven RUNX2 S-palmitoylation attenuates ferroptosis and enhances chemoresistance in ovarian cancer via the YAP1\/GLS1 axis"],"prefix":"10.1007","volume":"31","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2349_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5694\/mja2.52227","volume":"220","author":"M Sideris","year":"2024","unstructured":"Sideris M, Menon U, Manchanda R (2024) Screening and prevention of ovarian cancer. Med J Australia 220:264\u2013274","journal-title":"Med J Australia"},{"key":"2349_CR2","doi-asserted-by":"crossref","unstructured":"Jamali Z, Razipour M, Zargar M, Ghasemnejad-Berenji H, Akrami SM (2025) Ovarian cancer extracellular vesicle biomarkers, Clin Chimica Acta. 565:120011","DOI":"10.1016\/j.cca.2024.120011"},{"key":"2349_CR3","first-page":"389","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ (2024) Global epidemiology of epithelial ovarian cancer, Nature reviews. Clin Oncol 21:389\u2013400","journal-title":"Clin Oncol"},{"key":"2349_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA (2023) Clinical and translational advances in ovarian cancer therapy. Nat cancer 4:1239\u20131257","journal-title":"Nat cancer"},{"key":"2349_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","volume":"9","author":"DL Richardson","year":"2023","unstructured":"Richardson DL, Eskander RN, O\u2019Malley DM (2023) Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance: a narrative review. JAMA Oncol 9:851\u2013859","journal-title":"JAMA Oncol"},{"key":"2349_CR6","doi-asserted-by":"crossref","unstructured":"Yang L, Xie HJ, Li YY, Wang X, Liu XX, Mai J (2022) Molecular mechanisms of platinum\u2013based chemotherapy resistance in ovarian cancer (Review). Oncol Rep 47(4):1-11","DOI":"10.3892\/or.2022.8293"},{"key":"2349_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, Tang Q, Li Q, Zhang C, Wang H, Zou D (2024) Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer 23:66","journal-title":"Mol Cancer"},{"key":"2349_CR8","doi-asserted-by":"crossref","unstructured":"Zhang R, Siu MKY, Ngan HYS, Chan KKL (2022) Molecular biomarkers for the early detection of ovarian cancer. Int J Mol Sci 23(19):1204123","DOI":"10.3390\/ijms231912041"},{"key":"2349_CR9","doi-asserted-by":"publisher","first-page":"1598279","DOI":"10.3389\/fphar.2025.1598279","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Ouyang D, Liu M, Xiang Y, Li Z (2025) Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms. Front Pharmacol 16:1598279","journal-title":"Front Pharmacol"},{"key":"2349_CR10","doi-asserted-by":"publisher","first-page":"1410018","DOI":"10.3389\/fimmu.2024.1410018","volume":"15","author":"K Guo","year":"2024","unstructured":"Guo K, Lu M, Bi J, Yao T, Gao J, Ren F, Zhu L (2024) Ferroptosis: mechanism, immunotherapy and role in ovarian cancer. Front Immunol 15:1410018","journal-title":"Front Immunol"},{"key":"2349_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-023-01721-6","volume":"9","author":"D Ruan","year":"2023","unstructured":"Ruan D, Wen J, Fang F, Lei Y, Zhao Z, Miao Y (2023) Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential. Cell death discovery 9:434","journal-title":"Cell death discovery"},{"key":"2349_CR12","doi-asserted-by":"publisher","first-page":"107729","DOI":"10.1016\/j.phrs.2025.107729","volume":"215","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Lu L, Chen X, Yin Q (2025) Natural compounds targeting ferroptosis in ovarian cancer: research progress and application potential. Pharmacol Res 215:107729","journal-title":"Pharmacol Res"},{"key":"2349_CR13","doi-asserted-by":"publisher","first-page":"1578723","DOI":"10.3389\/fimmu.2025.1578723","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu X, Liu Q, Jiang Z, Wang G, Liao L, Ye X, Xing M, Sun H, Liu Q, Liu H (2025) Targeting ferroptosis: a promising avenue for ovarian cancer treatment. Front Immunol 16:1578723","journal-title":"Front Immunol"},{"key":"2349_CR14","doi-asserted-by":"publisher","first-page":"122720","DOI":"10.1016\/j.lfs.2024.122720","volume":"349","author":"C Kapper","year":"2024","unstructured":"Kapper C, Oppelt P, Arbeithuber B, Gyunesh AA, Vilusic I, Stelzl P (2024) Rezk-F\u00fcreder, Targeting ferroptosis in ovarian cancer: novel strategies to overcome chemotherapy resistance. Life Sci 349:122720","journal-title":"Life Sci"},{"key":"2349_CR15","doi-asserted-by":"crossref","unstructured":"Guo W, Wang W, Lei F, Zheng R, Zhao X, Gu Y, Yang M, Tong Y, Wang Y (2024) Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4. Biomed pharmacother 175:116680","DOI":"10.1016\/j.biopha.2024.116680"},{"key":"2349_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbrc.2023.04.111","volume":"665","author":"B Ma","year":"2023","unstructured":"Ma B, Zhong Y, Chen R, Zhan X, Huang G, Xiong Y, Tan B (2023) Tripterygium glycosides reverse chemotherapy resistance in ovarian cancer by targeting the NRF2\/GPX4 signal axis to induce ferroptosis of drug-resistant human epithelial ovarian cancer cells. Biochem Biophys Res Commun 665:178\u2013186","journal-title":"Biochem Biophys Res Commun"},{"key":"2349_CR17","doi-asserted-by":"crossref","unstructured":"Lin TC (2023) RUNX2 and, cancer Int J Mol Sci 24","DOI":"10.3390\/ijms24087001"},{"key":"2349_CR18","doi-asserted-by":"publisher","first-page":"e74384","DOI":"10.1371\/journal.pone.0074384","volume":"8","author":"ZQ Wang","year":"2013","unstructured":"Wang ZQ, Keita M, Bachvarova M, Gobeil S, Morin C, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Trinh XB, Bachvarov D (2013) Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells. PLoS ONE 8:e74384","journal-title":"PLoS ONE"},{"key":"2349_CR19","doi-asserted-by":"publisher","first-page":"110849","DOI":"10.1016\/j.cellsig.2023.110849","volume":"110","author":"K Tyagi","year":"2023","unstructured":"Tyagi K, Roy A, Mandal S (2023) Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK\/ERK1\/2\/Runx2 signalling axis. Cell Signal 110:110849","journal-title":"Cell Signal"},{"key":"2349_CR20","doi-asserted-by":"crossref","unstructured":"Huang Y, Liang L, Zhao YX, Yao BH, Zhang RM, Song L, Zhang ZT (2023) RUNX2 reverses p53-induced chemotherapy resistance in gastric cancer. Pharmacogenom Personal Med 16:253\u2013261","DOI":"10.2147\/PGPM.S394393"},{"key":"2349_CR21","doi-asserted-by":"crossref","unstructured":"Lv F, Si W, Xu X, He X, Wang Y, Li Y, Li F (2024) RUNX2 prompts triple negative breast cancer drug resistance through TGF-\u03b2 pathway regulating breast cancer stem cells 48:100967","DOI":"10.1016\/j.neo.2024.100967"},{"key":"2349_CR22","doi-asserted-by":"crossref","unstructured":"Huang J, Jia R, Guo J (2025) RUNX2 isoform II protects cancer cells from ferroptosis and apoptosis by promoting PRDX2 expression in oral squamous cell carcinoma. eLife 13:RP99122","DOI":"10.7554\/eLife.99122"},{"key":"2349_CR23","doi-asserted-by":"publisher","first-page":"10446","DOI":"10.18632\/aging.205940","volume":"16","author":"W Li","year":"2024","unstructured":"Li W, Guo Y, Xu Z, Li F, Dong Y, Xu F (2024) Notoginsenoside R1 (NGR1) regulates the AGE-RAGE signaling pathway by inhibiting RUNX2 expression to accelerate ferroptosis in breast cancer cells. Aging 16:10446\u201310461","journal-title":"Aging"},{"key":"2349_CR24","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, Ceccarelli M, Bontempi G (2016) Noushmehr, TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44:e71","journal-title":"Nucleic Acids Res"},{"key":"2349_CR25","doi-asserted-by":"crossref","unstructured":"Liu S, Wang Z, Zhu R, Wang F, Cheng Y, Liu Y (2021) Three differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2. J Vis Exp: JoVE","DOI":"10.3791\/62528-v"},{"key":"2349_CR26","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W (2009) Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc 4:1184\u20131191","journal-title":"Nat Protoc"},{"key":"2349_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S (2017) The ClusPro web server for protein-protein docking. Nat Protoc 12:255\u2013278","journal-title":"Nat Protoc"},{"key":"2349_CR28","doi-asserted-by":"publisher","first-page":"W140","DOI":"10.1093\/nar\/gkaa275","volume":"48","author":"D Wang","year":"2020","unstructured":"Wang D, Liu D, Yuchi J, He F, Jiang Y, Cai S, Li J, Xu D (2020) MusiteDeep: a deep-learning based webserver for protein post-translational modification site prediction and visualization. Nucleic Acids Res 48:W140\u2013w146","journal-title":"Nucleic Acids Res"},{"key":"2349_CR29","doi-asserted-by":"crossref","unstructured":"Cui J, Chen Y, Yang Q, Zhao P, Yang M, Wang X, Mang G, Yan X, Wang D, Tong Z, Wang P, Kong Y, Wang N, Wang D, Dong N, Liu M, Zhang MEM, Yu B (2024) Protosappanin A protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4\/FTH1 axis-dependent ferroptosis Adv Sci 11 e2310227","DOI":"10.1002\/advs.202310227"},{"key":"2349_CR30","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1111\/cas.15045","volume":"112","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zhou K, Wang Q, Huang Y, Ji J, Peng Y, Zhang X, Zheng T, Zhang Z, Chong D, Yang Z (2021) The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis. Cancer Sci 112:3533\u20133544","journal-title":"Cancer Sci"},{"key":"2349_CR31","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1158\/0008-5472.CAN-11-3343","volume":"72","author":"L van der Weyden","year":"2012","unstructured":"van der Weyden L, Papaspyropoulos A, Poulogiannis G, Rust AG, Rashid M, Adams DJ, Arends MJ (2012) O\u2019Neill, Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis. Cancer Res 72:3817\u20133827","journal-title":"Cancer Res"},{"key":"2349_CR32","doi-asserted-by":"crossref","unstructured":"Yang JX, Xie P, Li YS, Wen T, Yang XC (2020) Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2, Cellular Signal 70:109504","DOI":"10.1016\/j.cellsig.2019.109504"},{"key":"2349_CR33","doi-asserted-by":"crossref","unstructured":"Chen Y, Cui Y, Li M, Xia M, Xiang Q, Mao Y, Li H, Chen J, Zeng W, Zheng X, Peng J, Dai X, Tang Z (2024) A novel mechanism of ferroptosis inhibition-enhanced atherosclerotic plaque stability: YAP1 suppresses vascular smooth muscle cell ferroptosis through GLS1 FASEB J: Off Publ Federation Am Soc Exp Biol. 38:e23850","DOI":"10.1096\/fj.202401251R"},{"key":"2349_CR34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang B, Wang H, Liu S, Hao M, Luo D, Zhou Y, Huang Y, Nian Y, Zhang L, Chu B, Yin C (2025) Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat Commun 16:867","journal-title":"Nat Commun"},{"key":"2349_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.13308","volume":"17","author":"B Zhou","year":"2023","unstructured":"Zhou B, Hao Q, Liang Y, Kong E (2023) Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol Oncol 17:3\u201326","journal-title":"Mol Oncol"},{"key":"2349_CR36","doi-asserted-by":"publisher","first-page":"1342830","DOI":"10.3389\/fphar.2023.1342830","volume":"14","author":"D Liao","year":"2023","unstructured":"Liao D, Huang Y, Liu D, Zhang H, Shi X, Li X, Luo P (2023) The role of s-palmitoylation in neurological diseases: implication for zDHHC family. Front Pharmacol 14:1342830","journal-title":"Front Pharmacol"},{"key":"2349_CR37","doi-asserted-by":"crossref","unstructured":"Liu SF, Kucherenko MM, Sang P, Li Q, Yao J, Nambiar Veetil N, Gransar T, Alesutan I, Voelkl J, Salinas G, Grune J, Simmons S, Knosalla C, Kuebler WM (2024) RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease Eur Respir J 64(5):2300844","DOI":"10.1183\/13993003.00844-2023"},{"key":"2349_CR38","doi-asserted-by":"crossref","unstructured":"Lu L, Ye J, Yi D, Qi T, Luo T, Wu S, Yang L, Li L, Zhang H, Chen D (2024) Runx2 suppresses astrocyte activation and astroglial scar formation after spinal cord injury in mice. Mol Neurobiol 61:10820\u201310829","DOI":"10.1007\/s12035-024-04212-6"},{"key":"2349_CR39","doi-asserted-by":"publisher","first-page":"70916","DOI":"10.18632\/oncotarget.20200","volume":"8","author":"MS Kim","year":"2017","unstructured":"Kim MS, Gernapudi R, Choi EY, Lapidus RG, Passaniti A (2017) Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity. Oncotarget 8:70916\u201370940","journal-title":"Oncotarget"},{"key":"2349_CR40","doi-asserted-by":"publisher","first-page":"100474","DOI":"10.1016\/j.jbo.2023.100474","volume":"39","author":"D Green","year":"2023","unstructured":"Green D, Singh A, Tippett VL, Tattersall L, Shah KM, Siachisumo C, Ward NJ, Thomas P, Carter S, Jeys L, Sumathi V, McNamara I, Elliott DJ, Gartland A, Dalmay T, Fraser WD (2023) YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522. J bone Oncol 39:100474","journal-title":"J bone Oncol"},{"key":"2349_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41419-021-03635-6","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Wu R, Yung MMH, Sun J, Li Z, Yang H, Zhang Y, Liu SS, Cheung ANY, Ngan HYS, Braisted JC, Zheng W, Wei H, Gao Y, Nemes P, Pei H, Chan DW, Li Y, Zhu W (2021) SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance. Cell Death Dis 12:341","journal-title":"Cell Death Dis"},{"key":"2349_CR42","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.apsb.2020.03.008","volume":"10","author":"M Yuan","year":"2020","unstructured":"Yuan M, Chen X, Sun Y, Jiang L, Xia Z, Ye K, Jiang H, Yang B, Ying M, Cao J, He Q (2020) ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression. Acta Pharm Sinica B 10:1426\u20131439","journal-title":"Acta Pharm Sinica B"},{"key":"2349_CR43","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s11427-021-2048-2","volume":"65","author":"X Pei","year":"2022","unstructured":"Pei X, Li KY, Shen Y, Li JT, Lei MZ, Fang CY, Lu HJ, Yang HJ, Wen W, Yin M, Qu J, Lei QY (2022) Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Sci China Life Sci 65:2017\u20132030","journal-title":"Sci China Life Sci"},{"key":"2349_CR44","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/cas.16085","volume":"115","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liao X, Wang M, Liu J, Han J, An D, Zheng T, Wang X, Cheng H, Liu P (2024) Inhibition of palmitoyltransferase ZDHHC12 sensitizes ovarian cancer cells to cisplatin through ROS-mediated mechanisms. Cancer Sci 115:1170\u20131183","journal-title":"Cancer Sci"},{"key":"2349_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1210\/en.2013-1712","volume":"155","author":"K Gunaratnam","year":"2014","unstructured":"Gunaratnam K, Vidal C, Gimble JM, Duque G (2014) Mechanisms of palmitate-induced lipotoxicity in human osteoblasts. Endocrinology 155:108\u2013116","journal-title":"Endocrinology"},{"key":"2349_CR46","doi-asserted-by":"crossref","unstructured":"Bum-Erdene K, Ghozayel MK, Zhang MJ, Gonzalez-Gutierrez G, Meroueh SO (2023) Chloroacetamide fragment library screening identifies new scaffolds for covalent inhibition of the TEAD\u00b7YAP1 interaction, RSC Med Chem 14:1803\u20131816","DOI":"10.1039\/D3MD00264K"},{"key":"2349_CR47","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1021\/acs.jpcb.3c07073","volume":"128","author":"KR Mills","year":"2024","unstructured":"Mills KR, Misra J, Torabifard H (2024) Allosteric modulation of the YAP\/TAZ-TEAD interaction by palmitoylation and small-molecule inhibitors. J Phys Chem 128:3795\u20133806","journal-title":"J Phys Chem"},{"key":"2349_CR48","first-page":"e2409883","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, Shen D, Jiang J, Hu L, Fang K, Xie C, Shen N, Zhou Y, Wang Y, Du S, Meng S (2025) Dietary palmitic acid drives a palmitoyltransferase ZDHHC15-YAP feedback loop promoting tumor metastasis. Adv Sci 12:e2409883","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"2349_CR49","first-page":"119329","volume":"1869","author":"R Ebrahimighaei","year":"2022","unstructured":"Ebrahimighaei R, Sala-Newby GB, Hudson C, Kimura TE, Hathway T, Hawkins J, McNeill MC, Richardson R, Newby AC, Bond M (2022) Combined role for YAP-TEAD and YAP-RUNX2 signalling in substrate-stiffness regulation of cardiac fibroblast proliferation, Biochimica et biophysica acta. Mol cell Res 1869:119329","journal-title":"Mol cell Res"},{"key":"2349_CR50","doi-asserted-by":"publisher","first-page":"eadg0478","DOI":"10.1126\/sciadv.adg0478","volume":"9","author":"G Zhong","year":"2023","unstructured":"Zhong G, Su S, Li J, Zhao H, Hu D, Chen J, Li S, Lin Y, Wen L, Lin X, Xian G, Xu D, Zeng Q (2023) Activation of Piezo1 promotes osteogenic differentiation of aortic valve interstitial cell through YAP-dependent glutaminolysis. Sci Adv 9:eadg0478","journal-title":"Sci Adv"},{"key":"2349_CR51","doi-asserted-by":"publisher","first-page":"216619","DOI":"10.1016\/j.canlet.2024.216619","volume":"584","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang Y, Shen N, Liu Y, Xu X, Zhu R, Jiang H, Wu X, Wei Y, Tang J (2024) AMPK\u03b11-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Cancer Lett 584:216619","journal-title":"Cancer Lett"},{"key":"2349_CR52","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","volume":"6","author":"L Zhou","year":"2025","unstructured":"Zhou L, Lian G, Zhou T, Cai Z, Yang S, Li W, Cheng L, Ye Y, He M, Lu J, Deng Q, Huang B, Zhou X, Lu D, Zhi F, Cui J (2025) Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. Nat cancer 6:768\u2013785","journal-title":"Nat cancer"},{"key":"2349_CR53","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-22-3105","volume":"83","author":"Y Sun","year":"2023","unstructured":"Sun Y, Zhu L, Liu P, Zhang H, Guo F, Jin X (2023) ZDHHC2-mediated AGK palmitoylation activates AKT-mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma. Cancer Res 83:2034\u20132051","journal-title":"Cancer Res"},{"key":"2349_CR54","doi-asserted-by":"publisher","first-page":"216696","DOI":"10.1016\/j.canlet.2024.216696","volume":"587","author":"L Chen","year":"2024","unstructured":"Chen L, Xing X, Zhu Y, Chen Y, Pei H, Song Q, Li J, Zhang P (2024) Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. Cancer Lett 587:216696","journal-title":"Cancer Lett"},{"key":"2349_CR55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/jog.15922","volume":"50","author":"F Liu","year":"2024","unstructured":"Liu F, Zhang Y, Xia X, Han J, Cao L (2024) Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2. J Obstet Gynaecol Res 50:864\u2013872","journal-title":"J Obstet Gynaecol Res"},{"key":"2349_CR56","doi-asserted-by":"crossref","unstructured":"Zhang P, Pan Y, Wu S, He Y, Wang J, Chen L, Zhang S, Zhang H, Zhao Y, Niu L, Gan M, Wang Y, Shen L (2023) L. Zhu, n-3 PUFA promotes ferroptosis in PCOS GCs by inhibiting YAP1 through activation of the hippo pathway. Nutrients 15(8):1927","DOI":"10.3390\/nu15081927"},{"key":"2349_CR57","doi-asserted-by":"crossref","unstructured":"Li K, Wei P, Li Z, Kuang W, Zhang M, Luo C, Cui K, Lin D, Chen Z (2026) Hydrostatic pressure regulates glutamine metabolism to promote bladder fibroblast activation via the Piezo1\/YAP1\/GLS1 axis. J Transl Med 24","DOI":"10.1186\/s12967-026-07855-2"},{"key":"2349_CR58","doi-asserted-by":"publisher","first-page":"1344971","DOI":"10.3389\/fendo.2024.1344971","volume":"15","author":"R Yan","year":"2024","unstructured":"Yan R, Cai H, Zhou X, Bao G, Bai Z, Ge RL (2024) Hypoxia-inducible factor-2\u03b1 promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells. Front Endocrinol 15:1344971","journal-title":"Front Endocrinol"},{"key":"2349_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/toxsci\/kfac089","volume":"190","author":"G Li","year":"2022","unstructured":"Li G, Xu Q, Cheng D, Sun W, Liu Y, Ma D, Wang Y, Zhou S, Ni C (2022) Caveolin-1 and its functional peptide CSP7 affect silica-induced pulmonary fibrosis by regulating fibroblast glutaminolysis. Toxicol Sci 190:41\u201353","journal-title":"official J Soc Toxicol"},{"key":"2349_CR60","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.21037\/tcr-22-1494","volume":"12","author":"ZQ Wang","year":"2023","unstructured":"Wang ZQ, Li YQ, Wang DY, Shen YQ (2023) Natural product piperlongumine inhibits proliferation of oral squamous carcinoma cells by inducing ferroptosis and inhibiting intracellular antioxidant capacity. Transl Cancer Res 12:2911\u20132922","journal-title":"Translational cancer Res"},{"key":"2349_CR61","doi-asserted-by":"crossref","unstructured":"Wu J, Qin T, Han W, Zhang C, Zhang X, Huang Z, Wu Y, Xu Y, Xu K, Ye W (2025) GLS1-mediated glutamine metabolism mitigates oxidative stress-induced matrix degradation, ferroptosis, and senescence in nucleus pulposus cells by modulating Fe(2+) homeostasis. Free Radical Biol Med 228:93\u2013107","DOI":"10.1016\/j.freeradbiomed.2024.12.043"},{"key":"2349_CR62","doi-asserted-by":"crossref","unstructured":"Fu X, Wu H, Li C, Deng G, Chen C (2024) YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH. Mol Cellular Biochem. 479:2415\u20132427","DOI":"10.1007\/s11010-023-04847-4"},{"key":"2349_CR63","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.7150\/ijbs.83264","volume":"19","author":"Y Zou","year":"2023","unstructured":"Zou Y, Zhao Z, Wang J, Ma L, Liu Y, Sun L, Song Y (2023) Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway. Int J Biol Sci 19:3099\u20133114","journal-title":"Int J Biol Sci"},{"key":"2349_CR64","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41419-023-06076-5","volume":"14","author":"T Han","year":"2023","unstructured":"Han T, Chen T, Chen L, Li K, Xiang D, Dou L, Li H, Gu Y (2023) HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway. Cell Death Dis 14:606","journal-title":"Cell Death Dis"},{"key":"2349_CR65","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1002\/jcb.26814","volume":"119","author":"CP Masamha","year":"2018","unstructured":"Masamha CP, LaFontaine P (2018) Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy. J Cell Biochem 119:6136\u20136145","journal-title":"J Cell Biochem"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02349-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02349-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02349-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:00:57Z","timestamp":1782849657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02349-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02349-4","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments were approved by the Institutional Animal Care and Use Committee of Jilin University (No.2025070201).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"146"}}